Brad OelmannChannel Advisor & President at Farrell Growth GroupSpeaker
Agenda Sessions
The Biostimulant Commercialization Gap: Why Products with Positive Trials Still Fail—and How the Industry Can Improve the Odds
, 13:00View Session

